company background image
AVTR

Avantor NYSE:AVTR Stock Report

Last Price

US$21.29

Market Cap

US$14.4b

7D

4.7%

1Y

-47.7%

Updated

05 Oct, 2022

Data

Company Financials +
AVTR fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance5/6
Financial Health3/6
Dividends0/6

AVTR Stock Overview

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Avantor, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Avantor
Historical stock prices
Current Share PriceUS$21.29
52 Week HighUS$42.48
52 Week LowUS$19.54
Beta1.34
1 Month Change-13.10%
3 Month Change-32.56%
1 Year Change-47.73%
3 Year Change48.99%
5 Year Changen/a
Change since IPO46.83%

Recent News & Updates

Oct 05

Avantor raised to Buy at Citi on valuation disconnect

Citi upgraded the life sciences company Avantor, Inc. (NYSE:AVTR) to Buy from Hold on Wednesday, arguing that a moderate disconnect between its valuation and fundamentals indicates an attractive entry point to the stock at the current levels. The analyst Patrick Donnelly and the team point out that the AVTR, with a YTD decline of 51%, has underperformed Citi’s Tools Composite Index comprised of companies such as Agilent (A) and Danaher (DHR). However, in terms of EV/EBITDA, AVTR trades at a discount to the peer group even as the company outperforms the rivals in terms of consensus projections for FY23 revenue growth and adj. EBITDA margin expansion, the team, pointed out. Citi also argues that the recent selloff in AVTR shares adequately accounts for the recent downward revisions to guidance and risk to financials triggered by concerns such as softer than expected M&A contribution, the impact of the China lockdown, and weak industrial demand in Europe. In September, AVTR drew downgrades on Wall Street after the management lowered the revenue guidance.

Oct 03
Do Avantor's (NYSE:AVTR) Earnings Warrant Your Attention?

Do Avantor's (NYSE:AVTR) Earnings Warrant Your Attention?

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Sep 21
We Think Avantor (NYSE:AVTR) Can Stay On Top Of Its Debt

We Think Avantor (NYSE:AVTR) Can Stay On Top Of Its Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Sep 09
Is Avantor, Inc. (NYSE:AVTR) Potentially Undervalued?

Is Avantor, Inc. (NYSE:AVTR) Potentially Undervalued?

Today we're going to take a look at the well-established Avantor, Inc. ( NYSE:AVTR ). The company's stock received a...

Shareholder Returns

AVTRUS Life SciencesUS Market
7D4.7%7.1%4.4%
1Y-47.7%-26.5%-18.2%

Return vs Industry: AVTR underperformed the US Life Sciences industry which returned -26.5% over the past year.

Return vs Market: AVTR underperformed the US Market which returned -18.2% over the past year.

Price Volatility

Is AVTR's price volatile compared to industry and market?
AVTR volatility
AVTR Average Weekly Movement5.9%
Life Sciences Industry Average Movement9.6%
Market Average Movement6.9%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: AVTR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: AVTR's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
190413,500Michael Stubblefieldhttps://www.avantorsciences.com

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies.

Avantor, Inc. Fundamentals Summary

How do Avantor's earnings and revenue compare to its market cap?
AVTR fundamental statistics
Market CapUS$14.35b
Earnings (TTM)US$572.10m
Revenue (TTM)US$7.60b

25.1x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AVTR income statement (TTM)
RevenueUS$7.60b
Cost of RevenueUS$5.00b
Gross ProfitUS$2.60b
Other ExpensesUS$2.03b
EarningsUS$572.10m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Oct 28, 2022

Earnings per share (EPS)0.85
Gross Margin34.21%
Net Profit Margin7.52%
Debt/Equity Ratio144.8%

How did AVTR perform over the long term?

See historical performance and comparison